Scansource Inc

Scansource Inc(SCSC)股票分析

$59.280

-0.729 (-1.23%)收盘时

Loading chart…
最高
60.560
开盘
60.280
成交量加权均价
59.64
成交量
190.25K
市值
1.08B
最低
59.090
成交额
11.35M
企业价值/息税折旧摊销前利润(TTM)
7.90

ScanSource, Inc. is a technology distributor converging technologies and to accelerate growth for channel sales partners across hardware, software as a service (SaaS), connectivity and cloud services. It uses multiple sales models to offer technology solutions from suppliers of specialty technologies, connectivity and cloud services. Its segments include Specialty Technology Solutions and Intelisys & Advisory. The Specialty Technology Solutions segment operates primarily in the United States and Brazil and includes specialty technology solutions distributed through a wholesale/resale sales model. This segment includes hardware, SaaS and subscription services. The Intelisys & Advisory segment operates in the United States and consists of sales and services to both channel sales partners and end users. This segment also includes Connectivity and Software-Defined Networking, Unified Communications as a Service and Contact Center as a Service, Security, Cloud/Data Center, among others.

AI 分析 of Scansource Inc (SCSC)

持有

ScanSource Inc is currently priced at $60.02, which is above the analyst target of $51, suggesting it may not be a good buy at this moment. The RSI is at 46.39, indicating it is neither overbought nor oversold, and the forward P/E ratio is 11.78, which is relatively attractive. However, the recent news indicates challenges with flat sales and a weak free cash flow margin of 2.9%, which could hinder growth. The main risk is the current price being 17.5% above the analyst target, suggesting potential downside.

分析师评级(4)

-27.46% 下跌空间
买入
2 买入
2 持有
0 卖出
当前: 59.28
最低
43.00
平均
43.00
最高
43.00

Barclays

2026-10-12

目标价

$51

Equal Weight

Raymond James

2024-08-15

目标价

—

持有

Northcoast Research

2023-12-19

目标价

$36

持有

Raymond James

2023-11-10

目标价

$35

买入

Northcoast Research

2023-08-23

目标价

—

强烈买入

估值指标

Scansource Inc(SCSC)当前预期市盈率为 11.78,5 年平均预期市盈率为 10.28。

预期市盈率

合理
5 年均值 P/E
10.28
当前P/E
11.78
高估
12.44
低估
8.13

预期 EV/EBITDA

高估
5 年均值 EV/EBITDA
6.79
当前EV/EBITDA
7.90
高估
7.70
低估
5.89

预期市销率

高估
5 年均值 P/S
0.27
当前P/S
0.32
高估
0.32
低估
0.22

Alphio AI 对 SCSC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%SCSC

$40.64

情景价格

基

基准

基准 · 50%SCSC

$35.85

情景价格

悲

悲观

悲观 · 25%SCSC

$29.95

情景价格

事件时间线

2026-09-02 (ET)

08:30:00

ScanSource Completes Acquisition of MicroAge for $220.5M

2026-08-20 (ET)

09:00:00

Sees Adjusted EPS $158M-$165M; FCF at Least $85M

09:00:00

ScanSource Reports Q4 Revenue of $953.1M, Acquires MicroAge

08:30:00

ScanSource to Acquire MicroAge for $220.5 Million

2026-06-30 (ET)

16:30:00

ScanSource Expands Partnership with HPE

资讯

SCSC 常见问题 —— 由 Alphio AI 解答

ScanSource, Inc. is a technology distributor converging technologies and to accelerate growth for channel sales partners across hardware, software as a service (SaaS), connectivity and cloud services. It uses multiple sales models to offer technology solutions from suppliers of specialty technologies, connectivity and cloud services. Its segments include Specialty Technology Solutions and Intelisys & Advisory. The Specialty Technology Solutions segment operates primarily in the United States and Brazil and includes specialty technology solutions distributed through a wholesale/resale sales model. This segment includes hardware, SaaS and subscription services. The Intelisys & Advisory segment operates in the United States and consists of sales and services to both channel sales partners and end users. This segment also includes Connectivity and Software-Defined Networking, Unified Communications as a Service and Contact Center as a Service, Security, Cloud/Data Center, among others. It operates in the Technology sector (WHOLESALE-COMPUTERS & PERIPHERAL EQUIPMENT & SOFTW industry).

ScanSource Inc is currently priced at $60.02, which is above the analyst target of $51, suggesting it may not be a good buy at this moment. The RSI is at 46.39, indicating it is neither overbought nor oversold, and the forward P/E ratio is 11.78, which is relatively attractive. However, the recent news indicates challenges with flat sales and a weak free cash flow margin of 2.9%, which could hinder growth. The main risk is the current price being 17.5% above the analyst target, suggesting potential downside.

4 analysts cover SCSC: 2 rate it Buy, 2 Hold and 0 Sell. The average price target is 43.00.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易